BioFocus provides innovative drug discovery that delivers targets, hits, leads and clinical candidates in all major therapeutic areas.
We employ over 200 industry experienced scientists at our research centers in the UK and the Netherlands, with business development offices in Hong Kong, Japan and the US.
Since its foundation in 1997, BioFocus has produced high quality data for its clients and this quality is assured by ISO9001 qualification.
BioFocus is a service division of Galapagos NV. Galapagos’ drug discovery division develops novel and disease-modifying drugs in a number of therapeutic areas for which there is a need for better medicines.
No reviews to display
BioFocus, in Collaboration with the UCL Institute of Neurology, Receives Rapid Response Innovation Award from The Michael J. Fox Foundation
25 Jun 2013
06 Feb 2013
21 Mar 2011
11 Jan 2011
27 Sep 2010